CNS relapses in patients with HER2-positive early breast cancer who have and have not received adjuvant trastuzumab: a retrospective substudy of the HERA trial (BIG 1-01)

2013207 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet Oncology

Volume 14, Issue 3, pp. 244-248

Field-Weighted Citation Impact: 6.13